they're helping normalize it
Additionally, Carmona et al
This multi-targeted approach addresses metabolic dysfunction from several angles simultaneously
Global GLP-1 receptor agonist market is expected to witness lucrative growth over the forecast period as increasing number of patients are opting for GLP-1 drugs due to their greater efficacy and lesser side effects compared to conventional diabetes medications
Nisha Dahiya +2 more Table of Contents Glucagon-like peptide-1 (GLP-1) medications are gaining popularity for their benefits for type-2-diabetes and weight management 1
Methods Using data from the EQ-DAPHNIE project, 5403 respondents aged 65 years or older were included from Canada (n=1312), United States (US) (n=1069), United Kingdom (UK) (n=970), Australia (n=1224), and New Zealand (n=828), with analyses conducted overall and by age groups (65-69, 70-74, 75-79, 80) for each country